Age Effects on Antidepressant-Induced Manic Conversion
Open Access
- 1 August 2004
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Pediatrics & Adolescent Medicine
- Vol. 158 (8) , 773-780
- https://doi.org/10.1001/archpedi.158.8.773
Abstract
Background Antidepressant drug therapy can precipitate mania in vulnerable individuals, but little is known about the effects of age on this phenomenon. Objective To pharmacoepidemiologically evaluate the risk of conversion to mania by antidepressant class and patient age. Design, Setting, and Patients Using an administrative national database of more than 7 million privately insured individuals, linked outpatient and pharmacy claims were analyzed for mental health users aged 5 to 29 years (N = 87 920). Main Outcome Measures The proportion and cumulative hazard of manic conversion were analyzed by antidepressant class and subject age among children, adolescents, and young adults with an anxiety or nonbipolar mood disorder in the United States between January 1, 1997, and December 31, 2001. Manic conversion was defined as a new diagnosis of bipolar illness. Results During median follow-up of 41 weeks (range, 8-251 weeks), manic conversion occurred in 4786 patients (5.4%). Multivariate analyses using time-dependent Cox proportional hazards models indicated that an increased risk of manic conversion was associated with antidepressant category vs no antidepressant exposure (hazard ratios: 2.1 for selective serotonin reuptake inhibitors,P<.001; 3.8 for "other" antidepressants,P<.001; and 3.9 for tricyclic antidepressants,P= .002). Antidepressant × age interactions revealed inverse age effects for selective serotonin reuptake inhibitors and other antidepressants (β = −.05;P<.001 for both) but not for tricyclic antidepressants (β = −.02;P= .25). Peripubertal children exposed to antidepressants were at highest risk of conversion (number needed to harm: 10 [95% confidence interval, 9-12] among 10- to 14-year-olds vs 23 [95% confidence interval, 21-25] among 15- to 29-year-olds). Conclusions Patient age is an effect modifier on the risk of antidepressant-associated manic conversion. Treatment with antidepressants is associated with highest conversion hazards among children aged 10 to 14 years.Keywords
This publication has 36 references indexed in Scilit:
- The Long-term Course of Rapid-Cycling Bipolar DisorderArchives of General Psychiatry, 2003
- Can Long-Term Treatment With Antidepressant Drugs Worsen the Course of Depression?The Journal of Clinical Psychiatry, 2003
- The Prognostic Significance of “Switching” in Patients With Bipolar Disorder: A 10-Year Prospective Follow-Up StudyAmerican Journal of Psychiatry, 2002
- Rising Prevalence of Antidepressants Among US YouthsPublished by American Academy of Pediatrics (AAP) ,2002
- Pediatric stimulant and selective serotonin reuptake inhibitor prescription trends: 1992 to 1998Journal of Developmental & Behavioral Pediatrics, 2001
- Trends in the Prescribing of Psychotropic Medications to PreschoolersJAMA, 2000
- Psychoactive Medication Prescribing Practices for U.S. Children: Gaps Between Research and Clinical PracticeJournal of the American Academy of Child & Adolescent Psychiatry, 1999
- Antidepressant-induced mania and cycle acceleration: a controversy revisitedAmerican Journal of Psychiatry, 1995
- Switch from Depression to Mania – A Record Study over Decades between 1920 and 1982Psychopathology, 1985
- Rapid cyclers, temperament, and antidepressantsComprehensive Psychiatry, 1983